Search clinical trials for: Sunitinib Malate

Total 676 results

Amsterdam UMC, location VUmc

Terminated

Phase II Study of Sunitinib Rechallenge in Patients With Metastatic Renal Cell Carcinoma

Metastatic Renal Cell Carcinoma

Netherlands
Novo Nordisk A/S

Completed

Combination of Recombinant Human IL-21 (rIL-21) and Sunitinib in Stage IV Renal Cell Carcinoma Patients

Renal Cell Carcinoma | Cancer

Germany, Netherlands
Janssen Research & Development, LLC

Completed

The CANTATA-M (CANagliflozin Treatment and Trial Analysis - Monotherapy) Trial

Diabetes Mellitus, Type 2

United States, Colombia, Mexico, Poland, Spain, India, Malaysia, Romania, South Africa, Sweden, Korea, Republic of, Estonia, Puerto Rico, Austria, Lithuania, Philippines, Guatemala, Iceland
Massachusetts General Hospital
Dana-Farber Cancer Institute; Beth Israel Deaconess Medical Center

Terminated

SU011248 in Combination With Irinotecan and Cetuximab as a Second Line Regimen for Stage IV Colorectal Cancer

Colorectal Carcinoma

United States
James Murrough

Completed

Ketamine For Suicidal Ideation

Suicidal Ideation

United States
Amgen

Completed

To Evaluate the Safety, Tolerability and Pharmacokinetics of AMG 386 When Used in Combination With AMG 706, Bevacizumab, Sorafenib, or Sunitinib.

Advanced Solid Tumors
California Pacific Medical Center Research Institute
Pfizer

Withdrawn

A Phase II Trial of Sunitinib and Nivolumab for KIT-mutated Advanced Melanoma

Melanoma

United States
GERCOR - Multidisciplinary Oncology Cooperative...
Pfizer; Ipsen

Unknown

A Study of Sunitinib Versus Placebo in Combination With Lanreotide in Patients With Progressive Advanced/Metastatic Midgut Carcinoid Tumors (SUNLAND)

Carcinoid Tumors

France, Belgium
GERCOR - Multidisciplinary Oncology Cooperative...

Completed

A Study of Sunitinib in Patients With Advanced Cholangiocarcinoma (SUN-CK)

Unresectable and Advanced Cholangiocarcinoma

France
Consorzio Oncotech
Quercegen Pharmaceuticals; Clinical Research Technology S.r.l.

Unknown

Isoquercetin as an Adjunct Therapy in Patients With Kidney Cancer Receiving First-line Sunitinib: a Phase I/II Trial (QUASAR)

Kidney Cancer | Renal Cell Carcinoma

Italy
Novartis Pharmaceuticals

Completed

Efficacy of Nilotinib in Adult Patients With Gastrointestinal Stromal Tumors Resistant to Imatinib and Sunitinib.

Gastrointestinal Stromal Tumors

Germany, Italy
Dana-Farber Cancer Institute
Massachusetts General Hospital; Pfizer; Beth Israel Deaconess Medical Center

Completed

SU011248 in Patients With Metastatic Mucosal or Acral/Lentiginous Melanoma

Mucosal Lentiginous Melanoma | Acral Lentiginous Malignant Melanoma

United States
Stamford Hospital

Withdrawn

Solifenacin Succinate Versus Placebo in Inner City Women Ages 20-45 With Overactive Bladder

Overactive Bladder | Urge Incontinence | Urinary Urge

United States
Janssen Research & Development, LLC

Completed

A Study to Assess the Bioequivalence of the Metformin Component of the Fixed Dose Combination Tablet of Canagliflozin and Metformin Extended Release With Respect to Metformin Extended Release Tablet Coadministered With Canagliflozin in Healthy Fed and Fasted Participants

Healthy

United States
Novartis Pharmaceuticals

Completed

Efficacy and Safety Comparison of RAD001 Versus Sunitinib in the First-line and Second-line Treatment of Patients With Metastatic Renal Cell Carcinoma (RECORD-3)

Renal Cell Carcinoma

Canada, United Kingdom, Hong Kong, Netherlands, United States, Thailand, Korea, Republic of, Spain, Australia, Denmark, Mexico, Germany, Turkey, Italy, France, Brazil, Peru, Taiwan, Argentina
US Oncology Research
Pfizer

Completed

Gemzar, Cisp, Sunitinib Urothelial Ca

Urothelial Cancer

United States
Sidney Kimmel Cancer Center at Thomas Jefferson...
Pfizer

Completed

Phase IB Study Using Sunitinib Plus Radiation Therapy for Cancer Patients

Cancer | Head and Neck Cancer | Thoracic Neoplasms | Nervous System Neoplasms | Pelvic Cancer

United States
Bassam Abdulkarim
Pfizer; Canadian Cancer Society (CCS)

Unknown

Combining Sunitinib, Temozolomide and Radiation to Treat Patients Diagnosed With Glioblastoma

Glioblastoma Multiforme

Canada
Janssen Research & Development, LLC

Completed

Effects of Co-administration of Canagliflozin 300 mg and Phentermine 15 mg With Placebo in the Treatment of Non-Diabetic Overweight and Obese Participants

Obesity

United States
University of Alabama at Birmingham
Pfizer

Terminated

Evaluation of Patients With Bulky GIST Using Sunitinib

Tumor

United States
SCRI Development Innovations, LLC
Pfizer

Completed

Neoadjuvant Sunitinib With Paclitaxel/Carboplatin in Patients With Triple-Negative Breast Cancer

Breast Cancer

United States
Sun Yat-sen University

Unknown

A Pilot Study of Genomic Sequencing Guided Individualized Therapy in Gastrointestinal Cancers, GITIC Study (GITIC)

Gastrointestinal Cancers

China
Rennes University Hospital

Completed

Validation of a Predictive Nomogram of Response or Resistance to Targeted Therapies in Metastatic Clear Cell Renal Cell Carcinoma (RTKI)

Metastatic Clear Cell Renal Cell Carcinoma

France
Progen Pharmaceuticals

Completed

Study of CGC-11047 When Used in Individual Combinations With 1) Gemcitabine or 2) Docetaxel or 3) Bevacizumab or 4) Erlotinib or 5) Cisplatin or 6) 5-Flurouracil or 7) Sunitinib in Patients With Advanced Solid Tumors or Lymphoma

Cancer

United States
Massachusetts General Hospital
Pfizer; Dana-Farber Cancer Institute; Brigham and Women's Hospital

Completed

Sunitinib Tumor Levels in Patients Not on Enzyme-Inducing Anti-Epileptic Drugs Undergoing Debulking Surgery for Recurrent Glioblastoma

Glioblastoma | Brain Tumor

United States
National University Hospital, Singapore

Unknown

Randomized Study of Doxorubicin and Cyclophosphamide With or Without Intermittent Sunitinib in the First-line Treatment of Locally Advanced or Metastatic Breast Cancer Patients With Measurable Primary Breast Tumor

Breast Cancer

Singapore
National University Hospital, Singapore

Unknown

Docetaxel With or Without Low-dose, Short Course Sunitinib in Refractory Solid Tumors

Breast Cancer | Gastric Cancer | Prostate Cancer | Non-small Cell Lung Cancer | Solid Tumors

Singapore
National University Hospital, Singapore

Unknown

Dose-dense Doxorubicin/Cyclophosphamide With Intermittent Low-dose Sunitinib in Breast Cancer Patients

Breast Cancer

Singapore
Washington University School of Medicine
Pfizer

Completed

A Phase I Study of SUNITINIB and Rapamycin in Advanced Non-Small Cell Lung Cancer (NSCLC) (SU/Rapamycin)

Non-Small Cell Lung Cancer

United States
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Unknown

Phase II Study of Anlotinib Versus Sunitinib in Patients With Advanced Renal Cell Carcinoma（RCC）

Anlotinib | RCC

China
Massachusetts General Hospital
Pfizer; Dana-Farber Cancer Institute; Beth Israel Deaconess Medical Center

Completed

Combination Sunitinib and Gemcitabine in Sarcomatoid and/or Poor-risk Patients With Metastatic Renal Cell Carcinoma

Renal Cell Carcinoma | Neoplasm Metastases

United States
Massachusetts General Hospital
Pfizer; Beth Israel Deaconess Medical Center

Withdrawn

Bevacizumab With or Without Sunitinib in Sunitinib-Refractory Renal Cell Carcinoma

Renal Cell Carcinoma
The Methodist Hospital Research Institute
Schering-Plough

Terminated

Study of Pegylated Alfa Interferon, Sunitinib and Tarceva in Patients With Metastatic RCC

Carcinoma, Renal Cell

United States
Peking University Cancer Hospital & Institute

Unknown

A Phase II Trila of Sunitinib Schedule 4/2 vs. Shedule 2/1 as First Line Therapy in Metastatic Renal Cell Carcinoma.

Metastatic Renal Cell Carcinoma

China
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

A Prospective Study of Acute Cardiovascular Effects of First-line Sunitinib in Metastatic Renal Cell Carcinoma Patients (SUnitinib Prospective CardiovasculaR Effect) (SUPER)

Heart Failure | Renal Cell Carcinoma | Hypertension | Cardiotoxicity

Canada
Markus Joerger
University of Basel

Completed

Cytochrom p450 3A4 and 1A2 Phenotyping for the Individualization of Treatment With Sunitinib or Erlotinib in Cancer Patients

Non Small-cell Lung Cancer | Renal-cell Cancer | Gastrointestinal Stroma Tumor

Switzerland
Memorial Sloan Kettering Cancer Center
Pfizer; Dana-Farber Cancer Institute; University of Pittsburgh; University of Virginia

Completed

Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma

Neurofibromatosis | Meningioma | CNS Cancer | Hemangioblastoma | Intracranial Hemangiopericytoma

United States
King Faisal Specialist Hospital & Research Center

Completed

A SU011248 Expanded Access Protocol for Systemic Therapy of Patients With Metastatic Renal Cell Carcinoma Who Are Ineligible for Participation in Other SU011248 Protocols But May Derive Benefit From Treatment With SU011248

Metastatic Renal Cell Carcinoma

Saudi Arabia
Duke University
Sanofi; Pfizer

Terminated

Multimodality Phase II Study in Prostate Cancer

Prostate Cancer

United States
University of Pennsylvania
National Institute of Mental Health (NIMH)

Withdrawn

Behavioral Health Services for Women Receiving Public Assistance

Mental Disorders

United States
University of Pennsylvania
National Institute on Drug Abuse (NIDA)

Completed

HIV Prevention Among Substance Abusing SMI

HIV Infections | Substance Abuse | Mentally Ill Persons

United States
University of Utah
National Comprehensive Cancer Network

Completed

Sunitinib for Metastatic Renal Cell Cancer With Imaging Biomarker Assessments for the Early Prediction of Tumor Response

Renal Cell Cancer

United States
Imperial College Healthcare NHS Trust

Withdrawn

Functional Imaging in the Assessment of mRCC Response to Sunitinib

Metastatic Renal Cell Carcinoma

United Kingdom
Pfizer

Terminated

A Trial Of CVX-060, An Anti-Angiogenic COVX-Body, In Combination With Sunitinib In Patients With Advanced Renal Cell Carcinoma

Solid Tumor

United States
Joseph Roscoe
National Cancer Institute (NCI)

Completed

Prevention of Delayed Nausea A Phase III Double-Blind Placebo-Controlled Clinical Trial

Nausea

United States
Radboud University Medical Center
Dutch Cancer Society

Completed

The Vascular and Metabolic Effects of Sunitinib in Patients With Metastatic Renal Cell Carcinoma

Renal Cell Carcinoma | Hypertension | Insulin Sensitivity | Renal Function

Netherlands
National Cancer Institute (NCI)

Terminated

Sunitinib to Treat Recurrent Brain Cancer

Glioblastoma Multiforme | Malignant Gliomas | Anaplastic Gliomas

United States
Instituto Mexicano del Seguro Social

Unknown

Effect of Citrulline on the Clinical and Biochemical Evolution of Patients With Sepsis. (CITRUSEP)

Sepsis

Mexico
KU Leuven
Agentschap voor Innovatie door Wetenschap en Technologie

Completed

Risk of QT-prolongation and Torsade de Pointes in Patients Treated With Acute Medication in a University Hospital (RISQ-PATH)

Delirium | QT-prolongation

Belgium
University Health Network, Toronto

Completed

A Study of Sunitinib in Recurrent and/or Metastatic Adenoid Cystic Carcinoma of the Salivary Glands

Adenoid Cystic Carcinoma | Salivary Gland Cancer

Canada

Search clinical trials for: Sunitinib Malate

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Liberia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations